July 2012 – News from the OAC

OAC Exhibits at the 29th Annual Meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS) June 18-21, the OAC was in attendance at the 29th Annual Meeting of the ASMBS in San Diego. We had an exhibit booth where we showcased our educational materials and educated new...

OCC Applauds FDA for Approval of New Obesity Drug

Today, members of the Obesity Care Continuum (OCC) applauded the Food and Drug Administration’s (FDA) approval of a new obesity drug – Belviq (lorcaserin HCl). Belviq is the first obesity drug to be approved in the past 13 years. To view the full release, click here.

“Take Five to Live Light” Campaign Launches!

The OAC and Orexigen Therapeutics have partnered on a national awareness campaign, called Take Five to Live Light. The campaign aims to educate the more than 93 million Americans affected by the disease of obesity to take five minutes to learn more about: how losing just 5 percent of...

Page 18 of 21:

© 2014 Obesity Action Coalition 4511 North Himes Avenue • Suite 250 • Tampa, Florida 33614 • (800) 717-3117